Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1989-11-13
1992-10-13
Waddell, Frederick E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514 94, 5142358, 514252, 514326, 514359, 514374, 514383, 514397, 514398, 514399, 514400, A01N 4364, A01N 4350, A01N 5700, A01N 4358
Patent
active
051551187
ABSTRACT:
Substituted imidazoles such as ##STR1## are useful as angiotensin II blockers. These compounds have activity in treating hypertension and congestive heart failure.
REFERENCES:
patent: 3772315 (1973-11-01), Regel et al.
patent: 4207324 (1980-06-01), Matsumura et al.
patent: 4226878 (1980-10-01), Iizuka et al.
patent: 4228167 (1980-10-01), Yamamoto et al.
patent: 4301169 (1981-11-01), Yamanaka et al.
patent: 4328349 (1982-05-01), Grayboyes et al.
patent: 4340598 (1982-07-01), Furukawa et al.
patent: 4347364 (1982-08-01), Walser et al.
patent: 4347365 (1982-08-01), Walser et al.
patent: 4355040 (1982-10-01), Furukawa et al.
patent: 4379927 (1983-04-01), Vorbruggen et al.
patent: 4402966 (1983-09-01), Yamanaka et al.
patent: 4435395 (1984-03-01), Loev et al.
patent: 4448781 (1984-05-01), Cross et al.
patent: 4463011 (1984-07-01), Ogata
patent: 4532331 (1985-07-01), Frazee et al.
patent: 4533669 (1985-08-01), Yamanaka et al.
patent: 4539322 (1985-09-01), Campbell et al.
patent: 4602031 (1986-07-01), Yamanaka et al.
patent: 4689182 (1987-08-01), Rafferty
patent: 4755518 (1988-07-01), Rafferty
patent: 4772602 (1988-09-01), Cho et al.
patent: 4883798 (1989-11-01), Petocz et al.
patent: 4927826 (1990-05-01), Guthrie et al.
Wong et al., Abstract No. 30, Hypertension, p. 340, vol. 12, No. 3, Sep. 1988, High Blood Pressure Council Mtg., San Francisco, CA, Sep. 18-Oct. 1, 1988, "X-6803 Methyl-2-N-Butyl-1-(4-(2-Carboxybenzamido)Benzyl-4-Chloroimidazole-5-Aceta te, Sodium Salt): A Novel Nonpeptide Angiotension II Receptor Antagonist".
Chiu et al., "Abstract No. 118.11, The Pharmacologist, vol. 30, p. A165, 1988, for ASPET Mtg., Montreal, Canada, Oct. 9-12, 1988:" Nonpeptide Angiotensin II (AII) Receptor Antagonists: Structure Function Studies.
Wong et al., Nonpeptide Angiotensin II Receptor Antagonists. I Pharmacological Characterization of 2-n-Butyl-Chloro-1(2-chlorobenzyl)imidazole-5-acetic Acid, Sodium Salt (S-8307), "J. Pharmacology and Experimental Therapeutics," vol. 147, No. 1, pp. 1-7 (Jun. 10, 1988).
Chiu et al., "Non-peptide Angiotensin II Receptor Antagonists, II, Pharmacology of S-8308," European Journal of Pharmacology, vol. 157, pp. 13-21 (Aug. 23, 1988).
Lindgren et al., "Potentiation of inflammatory reactions in guinea-pig skin by an angiotensin converting enzyme inhibitor (MK 422)", European Journal Pharmacolgy vol. 135, pp. 383-387, Jan. 1987.
Schmidt et al., J. Cardiovascular Pharmacology, vol. 8, pp. S100-105, Jun. 1986.
H. Torii, Takeda Kenkyuissholo, 40, No. 3/4, 180-191 (Aug. 2, 1982).
Pals et al., Circulation Research, 29, 673 (Dec. 1971).
Streeten and Anderson, Handbook of Hypertension, vol. 5, Clinical Pharmogy of Antihypertensive Drugs, A. E. Doyle (Editor), Elsevier Science Publishers B. V., p. 246 (1984).
Satoh et al., Cir. Res., 36/37 & Suppl. I: I-89, Jun. 1975.
Carini David J.
Duncia John J. V.
Wong Pancras C. B.
Criares T. J.
E. I. Du Pont de Nemours and Company
Waddell Frederick E.
LandOfFree
Method and composition for preventing NSAID-induced renal failur does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method and composition for preventing NSAID-induced renal failur, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method and composition for preventing NSAID-induced renal failur will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1300649